"Having worked in a hospital, I understand firsthand how difficult it can be for site staff to manage a clinical trial alongside their primary duties," says Medpace Clinical Research Associate Ondřej Hájek. In this latest blog, Ondřej shares his journey from bedside nursing to clinical research, his experience with the PACE training program, and more. Read the full blog: https://bit.ly/4cnvRpn
Medpace
Pharmaceutical Manufacturing
Cincinnati, OH 377,838 followers
Accelerating Drug, Biologic and Medical Device Clinical Development
About us
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 6,500 people across 46 countries.
- Website
-
http://www.medpace.com
External link for Medpace
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Cincinnati, OH
- Type
- Public Company
- Founded
- 1992
- Specialties
- Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals
Locations
-
Primary
Get directions
5375 Medpace Way
Cincinnati, OH 45227, US
Employees at Medpace
Updates
-
IPF clinical trials are complex, shaped by a rare patient population, unpredictable disease progression, and endpoint variability. Download this #respiratory article for insights on site selection and recruitment, patient-centric trial design, and endpoint protection for FVC, HRCT, and PROs: https://lnkd.in/g5iwD7M3 📍Connect with Medpace experts at the ERS Congress to discuss how our integrated, full-service approach can help accelerate complex respiratory trials: https://lnkd.in/eFttPBT5
-
Advancing neuroscience clinical development requires specialized expertise and a deep understanding of the patient journey. Medpace's Advanced Clinical Practitioners (ACPs) bring clinical and therapeutic-specific knowledge to support protocol development, study execution, and patient-focused trial delivery. Hear directly from our #neuroscience ACPs as they share their unique experience that they contribute to our team.
-
Ensuring that testing is scientifically sound, operationally consistent, and globally standardized requires experienced laboratory leadership that understands both the science and the regulatory landscape. In our latest expert Q&A, John "Mick" Robbins, Ph.D, BCLD(ABB), Director, Clinical Laboratory Sciences, discusses his career in laboratory medicine, the impact of automation and emerging technologies, and how Medpace’s global laboratory teams collaborate to support Sponsors throughout clinical development. Read the full blog: https://lnkd.in/eMq8Kyp6
-
Are you attending the ERS Congress in Barcelona? Our dedicated #respiratory experts will be on site to discuss how our full-service approach, embedded therapeutic expertise, and global resources can help accelerate clinical breakthroughs. Request a meeting with Puneet Agarwal and Cinzia Giansante to discuss your upcoming clinical development plans: https://lnkd.in/eFttPBT5
-
Medpace is featured in the Summer 2026 issue of International Clinical Trials published by Samedan Ltd, exploring key considerations shaping Alzheimer's clinical development from biomarkers and trial design to recruitment and retention. Read "Pioneering Progress in Alzheimer's Clinical Trials" authored by Filipe Brogueira Rodrigues, Teresa Leon M.D PhD, Guido Moesker, and Daniela Rae. Read the full issue here: https://lnkd.in/e_6zi4bC
-
-
SSIEM is just a few days away! Terence Eagleton, MBBS, is ready to connect in Helsinki to discuss how our specialized rare disease expertise and full-service approach can help accelerate your clinical development program. 📅 Connect with us at SSIEM: https://lnkd.in/eamcNKqt
-
-
Medpace Milan has expanded into a larger office, creating additional space for our growing team as we continue to expand our global operations. Interested in joining a global organization? Visit our site to explore opportunities and find your fit: https://bit.ly/3YWjlHH
-
-
-
-
-
+1
-
-
The #rheumatology landscape continues to evolve as new therapies, technologies, and strategies transform drug development. Explore the latest trends shaping rheumatology clinical development in 2026, including: ▶️ CAR T-cell therapy ▶️ IgG4-related disease ▶️ Lupus nephritis ▶️ Axial spondyloarthritis Discover key insights and innovations in our latest blog: https://lnkd.in/di-enhHD
-
-
First-in-Human (FIH) studies can require complicated patient recruitment, lengthy participant commitments, and specialized assessments that can introduce operational challenges. In this case study, Medpace experts share how a strategic, solutions-oriented approach supported the execution of a complex rare disease program. Learn how Medpace applied integrated Phase I expertise to navigate the challenges of this complex FIH study: https://lnkd.in/eRasY4ut
-